Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001567619-20-013189)

Filing Details

Accession Number:: 0001567619-20-013189
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-10 18:57:10
Reporting Period:: 2020-07-10

Accepted Time:: 2020-07-10 18:57:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882361	Aptose Biosciences Inc.	APTO	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1761333	K. Gregory Chow	C/O Aptose Biosciences Inc. 251 Consumers Road, Suite 1105 Toronto A6 M2J 4R3	Executive Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2020-07-10	126,668	$6.05	232,846	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of 225,000 restricted stock units, previously reported on a Form 4/A filed with the Securities and Exchange Commission on March 10, 2020.